HYPE, ASTER falls: Pre-IPO markets change the DEX derivatives game

The Hyperliquid [HYPE] vs. Aster [ASTER] debate has picked up again. While big names and public support can bring visibility, users are also looking closely at the nuances. At the same time, Hyperliquid is pushing into a new category with Pre-IPO perpetual markets, making the argument more interesting. Hyperliquid at a clear lead In a recent post on X, crypto analyst Ryker argued that Hyperliquid’s edge over Aster comes down to one thing: transparency. His point was that because Hyperliquid activity happens on a public chain, large whale trades are easier to track, discuss, and turn into market stories. That visibility keeps the platform in conversation and brings more traders in. At press time, Hyperliquid led DEX derivatives with about $7.62B in OI and $7.89B in 24h volume, while Aster had around $1.96B in OI and $1.70B in 24h volume. Pre-IPO perps from Hyperliquid This is now extending into product innovation. HIP-3 and TradeXYZ have added Pre-IPO perpetual markets to the docs, allowing traders to take price exposure to companies before they go public! Note that these are perpetual derivatives, not shares, IPO allocations, tokenized equity, or ownership rights. The pricing is designed around pre-listing price discovery. The oracle is linked to the company’s latest funding round, while the market decides the trading price. Once the IPO happens, the perp converts at the IPO price; if not, it settles using the average Pre-IPO price. $CBRS is already tradable, with an IPO expected on the 7th of May. Market favors the lead At the time of writing, HYPE was up 50.02%, while ASTER was down 9.14% over the same timeframe. HYPE also closed around $40.96, gaining 3.13% on the day, after trading between roughly $39.70 and $41.16. That gap says a lot. Aster may still have attention because of the names linked to it (read: Binance's Changpeng Zhao), but Hyperliquid seems to have the better use case. With Pre-IPO perps now entering the conversation, the market is clearly giving Hyperliquid more credit. Final Summary Hyperliquid dominates DEX derivatives, far ahead of Aster. Markets like Hyperliquid’s transparency and new Pre-IPO perp offering.